News

Global science-led biopharmaceutical company AstraZeneca Philippines has signed a memorandum of understanding (MOU) with the ...
Elizabeth Bodin is very excited about the FDA-approved FluMist, a nasal spray that can be ordered online and delivered to ...
The government is partnering with the local subsidiary of multinational pharmaceutical company AstraZeneca to develop the ...
FluMist Home is an influenza vaccine that’s administered via nasal spray, which means no needles and no waiting in line at ...
AstraZeneca is conducting a Phase 2a clinical study titled ‘A Phase 2a, Randomised, Double-Blind, Placebo-Controlled Study to Assess Efficacy and Safety of Atuliflapon Given Orally Once Daily for ...
FluMist, a nasal spray flu vaccine made by AstraZeneca, is now available for at-home use through a service called FluMist ...
AstraZeneca has issued its flu vaccine nasal spray for at-home use. The nasal spray is authorized for use by adults ages 18-49 and for caregiver use with children ages 2-17, according to an Aug. 15 ...
Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...
The Department of Trade and Industry (DTI), through the Philippine Economic Zone Authority (PEZA), has teamed up with ...
With Trump's backing, the pharma industry is leaning into the idea of more "direct-to-consumer" sales. But experts say the ...
AstraZeneca has launched FluMist Home, a nasal spray flu vaccine with at-home delivery service. For those who have a needle ...
Roche has found redemption in a precision medicine approach following an earlier Tecentriq trial flop in a broader bladder ...